- Home
- CZR vs BLTE Comparison
CZR vs BLTE Comparison
Compare CZR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CZR | BLTE |
|---|---|---|
| Founded | 1937 | 2018 |
| Country | United States | United States |
| Employees | 15500 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 6.5B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CZR | BLTE |
|---|---|---|
| Price | $26.57 | $166.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $30.00 | ★ $181.14 |
| AVG Volume (30 Days) | ★ 5.2M | 143.0K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,473,504,000.00 | N/A |
| Revenue This Year | $3.58 | N/A |
| Revenue Next Year | $2.49 | $363.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.03 | N/A |
| 52 Week Low | $17.86 | $49.00 |
| 52 Week High | $31.58 | $200.00 |
Technical Indicators
Market Signals| Indicator | CZR | BLTE |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 53.25 |
| Support Level | $23.29 | $148.06 |
| Resistance Level | $27.85 | $171.59 |
| Average True Range (ATR) | 0.87 | 7.90 |
| MACD | -0.28 | 0.39 |
| Stochastic Oscillator | 45.19 | 78.51 |
Price Performance
Historical ComparisonAbout CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (47% of the estimated 2025 EBITDAR before corporate expenses) and regional (49%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.